by The Economist
My articles My siteMy videosMy books
Follow on:LinkedINTwitterFacebookYoutubeAmazonGoogle +
| Cancer scientists will break new ground in 2017 with the approval of a tailored gene therapy called CAR-T. Next year could be the year for personalised medicine to go mainstream.
Click here to subscribe to The Economist on YouTube: http://econ.trib.al/rWl91R7 What are the breakthroughs we’ll all be talking about in the year ahead? A new type of medicine will be on all of our lips. It’s called personalised medicine. Personalised medicine customises treatment to an individual’s needs using their genes. It’s powerful, precise and effective. And there’s one breakthrough in particular that will get our attention – a new drug that marks a step change in our battle against cancer. 2017 will be important historically because of the approval of a gene therapy treatment, called CAR-T therapy. Daily Watch: mind-stretching short films every day of the working week. |
Tags:
